Literature DB >> 26745098

Incidence and Mortality of Breast Cancer and their Relationship with the Human Development Index (HDI) in the World in 2012.

Mahshid Ghoncheh1, Maryam Mirzaei, Hamid Salehiniya.   

Abstract

BACKGROUND: Breast cancer is the most common malignancy in women worldwide and its incidence is generally increasing. In 2012, it was the second most common cancer in the world. It is necessary to obtain information on incidence and mortality for health planning. This study aimed to investigate the relationship between the human development index (HDI), and the incidence and mortality rates of breast cancer in the world in 2012.
MATERIALS AND METHODS: This ecologic study concerns incidence rate and standardized mortality rates of the cancer from GLOBOCAN in 2012, and HDI and its components extracted from the global bank site. Data were analyzed using correlation tests and regression with SPSS software (version 15).
RESULTS: Among the six regions of WHO, the highest breast cancer incidence rate (67.6) was observed in the PAHO, and the lowest incidence rate was 27.8 for SEARO. There was a direct, strong, and meaningful correlation between the standardized incidence rate and HDI (r=0.725, p≤0.001). Pearson correlation test showed that there was a significant correlation between age-specific incidence rate (ASIR) and components of the HDI (life expectancy at birth, mean years of schooling, and GNP). On the other, a non-significant relationship was observed between ASIR and HDI overall (r=0.091, p=0.241). In total, a significant relationship was not found between age-specific mortality rate (ASMR) and components of HDI.
CONCLUSIONS: Significant positive correlations exist between ASIR and components of the HDI. Socioeconomic status is directly related to the stage of the cancer and patient's survival. With increasing the incidence rate of the cancer, mortality rate from the cancer does not necessariloy increase. This may be due to more early detection and treatment in developed that developing countries. It is necessary to increase awareness of risk factors and early detection in the latter.

Entities:  

Mesh:

Year:  2015        PMID: 26745098     DOI: 10.7314/apjcp.2015.16.18.8439

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  19 in total

Review 1.  Explaining pain following cancer: a practical guide for clinicians.

Authors:  Jo Nijs; Amarins J Wijma; Laurence Leysen; Roselien Pas; Ward Willaert; Wouter Hoelen; Kelly Ickmans; C Paul van Wilgen
Journal:  Braz J Phys Ther       Date:  2018-12-21       Impact factor: 3.377

2.  Epidemiology, incidence and mortality of lung cancer and their relationship with the development index in the world.

Authors:  Hosein Rafiemanesh; Mojtaba Mehtarpour; Farah Khani; Sayed Mohammadali Hesami; Reza Shamlou; Farhad Towhidi; Hamid Salehiniya; Behnam Reza Makhsosi; Ali Moini
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

3.  The incidence and mortality of esophageal cancer and their relationship to development in Asia.

Authors:  Reza Pakzad; Abdollah Mohammadian-Hafshejani; Bahman Khosravi; Shahin Soltani; Iraj Pakzad; Mahdi Mohammadian; Hamid Salehiniya; Zohre Momenimovahed
Journal:  Ann Transl Med       Date:  2016-01

4.  [MiR-4443 promotes migration and invasion of breast cancer cells by inhibiting PEBP1 expression].

Authors:  Jinyan Wang; Jinqiu Wang; Quan Gu; Yan Yang; Yajun Ma; Jing Zhu; Quanan Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-12-30

5.  Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern.

Authors:  Masoumeh Arabsalmani; Abdollah Mohammadian-Hafshejani; Mahshid Ghoncheh; Fatemeh Hadadian; Farhad Towhidi; Kamran Vafaee; Hamid Salehiniya
Journal:  J Nephropathol       Date:  2016-08-07

6.  Epidemiology and Inequality in the Incidence and Mortality of Nasopharynx Cancer in Asia.

Authors:  Neda Mahdavifar; Mahshid Ghoncheh; Abdollah Mohammadian-Hafshejani; Bahman Khosravi; Hamid Salehiniya
Journal:  Osong Public Health Res Perspect       Date:  2016-11-16

7.  miR-200b inhibits proliferation and metastasis of breast cancer by targeting fucosyltransferase IV and α1,3-fucosylated glycans.

Authors:  Q Zheng; X Cui; D Zhang; Y Yang; X Yan; M Liu; B Niang; F Aziz; S Liu; Q Yan; J Liu
Journal:  Oncogenesis       Date:  2017-07-10       Impact factor: 7.485

8.  Association between CYP17 T-34C rs743572 and breast cancer risk.

Authors:  Jing Sun; Hong Zhang; Meiyan Gao; Zhishu Tang; Dongyan Guo; Xiaofei Zhang; Zhu Wang; Ruiping Li; Yan Liu; Wansen Sun; Xi Sun
Journal:  Oncotarget       Date:  2017-12-26

9.  The incidence and mortality of ovarian cancer and their relationship with the Human Development Index in Asia.

Authors:  Saeid Razi; Mahshid Ghoncheh; Abdollah Mohammadian-Hafshejani; Hojjat Aziznejhad; Mahdi Mohammadian; Hamid Salehiniya
Journal:  Ecancermedicalscience       Date:  2016-03-24

10.  Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide.

Authors:  S Hassanipour-Azgomi; Abdollah Mohammadian-Hafshejani; Mahshid Ghoncheh; Farhad Towhidi; Saeid Jamehshorani; Hamid Salehiniya
Journal:  Prostate Int       Date:  2016-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.